Moslem Taheri-Soodejani, Marjan Rasoulian-Kasrineh, Seyyed-Mohammad Tabatabaei
{"title":"Metabolic Syndrome and Ischemic Stroke in Iran: Incidence and Disability-Adjusted Life Years 1990 to 2019.","authors":"Moslem Taheri-Soodejani, Marjan Rasoulian-Kasrineh, Seyyed-Mohammad Tabatabaei","doi":"10.1089/met.2023.0253","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Metabolic syndrome (MS) is one of the conditions that may increase the risk of ischemic stroke (IS). This study focuses on factors of MS related to the incidence, years of life lost (YLL), and years of life disability (YLD) caused by IS. <b><i>Materials and Methods:</i></b> The age-adjusted data (incidence, YLL, and YLD) related to four factors of MS [fasting plasma glucose, body mass index (BMI), low-density lipoprotein, and systolic blood pressure, SBP] were extracted as risk factors for IS during the years 1990 to 2019 from global burden of disease study. ARC GIS V.10 software was used to investigate the geographical distribution and the Cochran-Armitage test was used to investigate the trend of these indices. <b><i>Results:</i></b> The highest incidence of IS was reported in Golestan provinces in 2019 [women: 180 (95% UI 153-213), men: 163 (95% UI 141-191), and both genders: 172 (95% UI 149-201)]. High SBP has the highest impact on YLD (96-102 per 100,000 population in some provinces) and YLL (688-824 per 100,000 population in some provinces) in men and women (YLD: 126-156, YLL: 586-785 per 100,000 population in some provinces). High BMI has increased YLD caused by IS from 1990 (35 per 100,000 population) to 2019 (53 per 100,000 population). <b><i>Conclusion:</i></b> Considering the importance of IS and the impact that MS has on this disease, it seems that one of the most effective possible measures is to eliminate MS. The factors of MS are mostly related to lifestyle, and MS can be controlled with a suitable plan, which can be considered as primary prevention for IS.</p>","PeriodicalId":18405,"journal":{"name":"Metabolic syndrome and related disorders","volume":" ","pages":"337-345"},"PeriodicalIF":1.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic syndrome and related disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/met.2023.0253","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Metabolic syndrome (MS) is one of the conditions that may increase the risk of ischemic stroke (IS). This study focuses on factors of MS related to the incidence, years of life lost (YLL), and years of life disability (YLD) caused by IS. Materials and Methods: The age-adjusted data (incidence, YLL, and YLD) related to four factors of MS [fasting plasma glucose, body mass index (BMI), low-density lipoprotein, and systolic blood pressure, SBP] were extracted as risk factors for IS during the years 1990 to 2019 from global burden of disease study. ARC GIS V.10 software was used to investigate the geographical distribution and the Cochran-Armitage test was used to investigate the trend of these indices. Results: The highest incidence of IS was reported in Golestan provinces in 2019 [women: 180 (95% UI 153-213), men: 163 (95% UI 141-191), and both genders: 172 (95% UI 149-201)]. High SBP has the highest impact on YLD (96-102 per 100,000 population in some provinces) and YLL (688-824 per 100,000 population in some provinces) in men and women (YLD: 126-156, YLL: 586-785 per 100,000 population in some provinces). High BMI has increased YLD caused by IS from 1990 (35 per 100,000 population) to 2019 (53 per 100,000 population). Conclusion: Considering the importance of IS and the impact that MS has on this disease, it seems that one of the most effective possible measures is to eliminate MS. The factors of MS are mostly related to lifestyle, and MS can be controlled with a suitable plan, which can be considered as primary prevention for IS.
简介代谢综合征(MS)是可能增加缺血性脑卒中(IS)风险的疾病之一。本研究的重点是 MS 与 IS 的发病率、寿命损失年数(YLL)和寿命残疾年数(YLD)相关的因素。材料与方法:从全球疾病负担研究中提取 1990 年至 2019 年期间与 MS 的四个因素[空腹血浆葡萄糖、体重指数 (BMI)、低密度脂蛋白和收缩压 (SBP)]相关的年龄调整后数据(发病率、YLL 和 YLD),作为 IS 的风险因素。使用 ARC GIS V.10 软件调查地理分布情况,使用 Cochran-Armitage 检验调查这些指数的变化趋势。结果显示据报告,2019 年戈勒斯坦省的 IS 发病率最高[女性:180(95% UI 153-213),男性:163(95% UI 141-191),男女均有:172 (95% UI 149-201)]。高 SBP 对男性和女性的 YLD(部分省份为 96-102 per 100,000 population)和 YLL(部分省份为 688-824 per 100,000 population)影响最大(YLD:126-156,YLL:586-785 per 100,000 population in some provinces)。高体重指数使IS导致的YLD从1990年(每10万人35例)增加到2019年(每10万人53例)。结论:考虑到 IS 的重要性以及 MS 对该疾病的影响,消除 MS 似乎是最有效的可行措施之一。多发性硬化症的发病因素大多与生活方式有关,多发性硬化症可通过适当的计划加以控制,这可被视为 IS 的初级预防。
期刊介绍:
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.
Metabolic Syndrome and Related Disorders coverage includes:
-Insulin resistance-
Central obesity-
Glucose intolerance-
Dyslipidemia with elevated triglycerides-
Low HDL-cholesterol-
Microalbuminuria-
Predominance of small dense LDL-cholesterol particles-
Hypertension-
Endothelial dysfunction-
Oxidative stress-
Inflammation-
Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout